497 related articles for article (PubMed ID: 8503189)
1. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
Park J; Morrow CD
Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
[TBL] [Abstract][Full Text] [Related]
2. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
Park J; Morrow CD
J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
[TBL] [Abstract][Full Text] [Related]
4. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
9. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
10. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
11. Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles.
Wang CT; Stegeman-Olsen J; Zhang Y; Barklis E
Virology; 1994 May; 200(2):524-34. PubMed ID: 8178440
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
14. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
Morin N; Cherry E; Li X; Wainberg MA
J Hum Virol; 1998; 1(3):240-7. PubMed ID: 10195247
[TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of the P2 region of the Rous sarcoma virus gag gene: effects on Gag polyprotein processing.
Bowles N; Bonnet D; Mulhauser F; Spahr PF
Virology; 1994 Aug; 203(1):20-8. PubMed ID: 8030280
[TBL] [Abstract][Full Text] [Related]
16. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
[TBL] [Abstract][Full Text] [Related]
17. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
[TBL] [Abstract][Full Text] [Related]
18. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
Cherry E; Morin N; Wainberg MA
AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
[TBL] [Abstract][Full Text] [Related]
19. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
[TBL] [Abstract][Full Text] [Related]
20. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
González SA; Affranchino JL
Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]